Achieve Operational Excellence, Regulatory Compliance & Minimize Risk in R&D & Manufacturing Sites

Companies in the room

Navigating the Future of Environmental, Health & Safety in Biopharma

As the biopharma industry evolves with rapid advancements in drug development, manufacturing, and research, EHS leaders are tasked with safeguarding employee health, maintaining a culture of safety, and addressing environmental concerns. Navigating these challenges while meeting sustainability goals and mitigating risks has become essential for operational success. EHS professionals must continuously adapt to this dynamic landscape to protect their most valuable asset: their workforce.

The 2nd EHS for Biopharma East Summit is an essential event for EHS professionals working in the biopharma industry, focused on overcoming the sector's unique regulatory and operational challenges. With over 100+ attendees, this summit will provide valuable insights on navigating evolving regulations, optimizing safety protocols, and enhancing environmental stewardship. Whether your goal is to strengthen safety culture, reduce incidents, or achieve sustainability targets, the summit offers the tools, knowledge, and networking opportunities necessary to elevate EHS practices.

Gain continuing education credits as you hear from EHS&S leaders at large global pharma companies like Sanofi, AstraZeneca, BMS, Astellas, Charles River, Amgen, CDMOs and CROs and small biotechs.

Earn credits from BCSP, ABSA & CIH!

World-Class Speaker Faculty Includes:

Previously Attending Companies Include:

55599 - Previously Attending Companies Include
ultragenyx

"This conference was outstanding. I particularly enjoyed the biopharmaceuticals industry focus number and diversity of attendees, all the topics and speakers.”  

- Global Head of Environment, Health, and Safety & Sustainability, Ultragenyx Pharmaceutical 

astraveneca

"It was great to bring peers together to discuss the key issues facing the industry and profession, as well as to hear about the strategies and approaches each organization is taking to address these challenges. The well-planned agenda, which included a diverse range of organizations—from large global companies to small, local ones—fostered engaging discussions and created an inclusive atmosphere."

- Head of Safety, Health, Environment & Global Operations, AstraZeneca

Our Partners

safetystratus
icl dover
scishield

Other Events in the Series